185 related articles for article (PubMed ID: 25818853)
1. Associations of multiple lipoprotein and apolipoprotein measures with worsening of glycemia and incident type 2 diabetes in 6607 non-diabetic Finnish men.
Fizelova M; Miilunpohja M; Kangas AJ; Soininen P; Kuusisto J; Ala-Korpela M; Laakso M; Stančáková A
Atherosclerosis; 2015 May; 240(1):272-7. PubMed ID: 25818853
[TBL] [Abstract][Full Text] [Related]
2. Association between lipids and apolipoproteins on type 2 diabetes risk; moderating effects of gender and polymorphisms; the ATTICA study.
Mellor DD; Georgousopoulou EN; D'Cunha NM; Naumovski N; Chrysohoou C; Tousoulis D; Pitsavos C; Panagiotakos DB;
Nutr Metab Cardiovasc Dis; 2020 May; 30(5):788-795. PubMed ID: 32127339
[TBL] [Abstract][Full Text] [Related]
3. Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study.
Ren XY; Shi D; Ding J; Cheng ZY; Li HY; Li JS; Pu HQ; Yang AM; He CL; Zhang JP; Ma YB; Zhang YW; Zheng TZ; Bai YN; Cheng N
Lipids Health Dis; 2019 Feb; 18(1):47. PubMed ID: 30744645
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study.
Bertrand C; Saulnier PJ; Potier L; Croyal M; Blanchard V; Gand E; Ragot S; Schneider F; Bocock O; Baillet-Blanco L; Velho G; Marre M; Roussel R; Rigalleau V; Hadjadj S; Mohammedi K;
Diabetologia; 2021 Mar; 64(3):668-680. PubMed ID: 33409569
[TBL] [Abstract][Full Text] [Related]
5. LDL/apo B ratio predict coronary heart disease in Type 2 diabetes independent of ASCVD risk score: A case-cohort study.
Rabizadeh S; Rajab A; Mechanick JI; Moosaie F; Rahimi Y; Nakhjavani M; Esteghamati A
Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1477-1485. PubMed ID: 33810957
[TBL] [Abstract][Full Text] [Related]
6. Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study.
Mora S; Buring JE; Ridker PM; Cui Y
Ann Intern Med; 2011 Dec; 155(11):742-50. PubMed ID: 22147713
[TBL] [Abstract][Full Text] [Related]
7. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
[TBL] [Abstract][Full Text] [Related]
8. Low-density lipoprotein cholesterol-to-apolipoprotein B ratio as a potential indicator of LDL particle size and plasma atherogenicity in type 2 diabetes.
Viktorinova A; Malickova D; Svitekova K; Choudhury S; Krizko M
Diabetes Res Clin Pract; 2021 Jun; 176():108858. PubMed ID: 34015391
[TBL] [Abstract][Full Text] [Related]
9. Role of High-Density Lipoproteins in Cholesterol Homeostasis and Glycemic Control.
Manandhar B; Cochran BJ; Rye KA
J Am Heart Assoc; 2020 Jan; 9(1):e013531. PubMed ID: 31888429
[No Abstract] [Full Text] [Related]
10. Metabolic markers associated with insulin resistance predict type 2 diabetes in Koreans with normal blood pressure or prehypertension.
Sung KC; Park HY; Kim MJ; Reaven G
Cardiovasc Diabetol; 2016 Mar; 15():47. PubMed ID: 27001495
[TBL] [Abstract][Full Text] [Related]
11. Adverse lipid profile elevates risk for subarachnoid hemorrhage: A prospective population-based cohort study.
Lindbohm J; Korja M; Jousilahti P; Salomaa V; Kaprio J
Atherosclerosis; 2018 Jul; 274():112-119. PubMed ID: 29772479
[TBL] [Abstract][Full Text] [Related]
12. Effects of glyburide treatment on serum lipoprotein and apolipoprotein concentrations and ratios in non-insulin-dependent diabetes mellitus.
Waysbort J; Regitz G; Brunner D
Clin Ther; 1988; 10(4):392-400. PubMed ID: 3152618
[TBL] [Abstract][Full Text] [Related]
13. Sex-specific differences in blood lipids and lipid ratios in type 2 diabetic foot patients.
Yin S; Zhao P; Ai Z; Deng B; Jia W; Wang H; Zheng J
J Diabetes Investig; 2021 Dec; 12(12):2203-2211. PubMed ID: 34137504
[TBL] [Abstract][Full Text] [Related]
14. Utility of non-high-density lipoprotein cholesterol in assessing incident type 2 diabetes risk.
Ley SH; Harris SB; Connelly PW; Mamakeesick M; Gittelsohn J; Wolever TM; Hegele RA; Zinman B; Hanley AJ
Diabetes Obes Metab; 2012 Sep; 14(9):821-5. PubMed ID: 22510237
[TBL] [Abstract][Full Text] [Related]
15. Lp(a) and Apo-lipoproteins as predictors for micro- and macrovascular complications of diabetes: A case-cohort study.
Moosaie F; Firouzabadi FD; Abouhamzeh K; Esteghamati S; Meysamie A; Rabizadeh S; Nakhjavani M; Esteghamati A
Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1723-1731. PubMed ID: 32636121
[TBL] [Abstract][Full Text] [Related]
16. Egg consumption and risk of incident type 2 diabetes in men: the Kuopio Ischaemic Heart Disease Risk Factor Study.
Virtanen JK; Mursu J; Tuomainen TP; Virtanen HE; Voutilainen S
Am J Clin Nutr; 2015 May; 101(5):1088-96. PubMed ID: 25832339
[TBL] [Abstract][Full Text] [Related]
17. Effect of niacin on high-density lipoprotein apolipoprotein A-I kinetics in statin-treated patients with type 2 diabetes mellitus.
Pang J; Chan DC; Hamilton SJ; Tenneti VS; Watts GF; Barrett PH
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):427-32. PubMed ID: 24285582
[TBL] [Abstract][Full Text] [Related]
18. Rates of cholesterol esterification and esterified cholesterol net mass transfer between high-density lipoproteins and apolipoprotein B-containing lipoproteins in Type 1 diabetes.
Valabhji J; Donovan J; McColl AJ; Schachter M; Richmond W; Elkeles RS
Diabet Med; 2002 May; 19(5):424-8. PubMed ID: 12027932
[TBL] [Abstract][Full Text] [Related]
19. Association of erythrocyte membrane fatty acids with changes in glycemia and risk of type 2 diabetes.
Mahendran Y; Ågren J; Uusitupa M; Cederberg H; Vangipurapu J; Stančáková A; Schwab U; Kuusisto J; Laakso M
Am J Clin Nutr; 2014 Jan; 99(1):79-85. PubMed ID: 24153340
[TBL] [Abstract][Full Text] [Related]
20. Markers of tissue-specific insulin resistance predict the worsening of hyperglycemia, incident type 2 diabetes and cardiovascular disease.
Fízel'ová M; Cederberg H; Stančáková A; Jauhiainen R; Vangipurapu J; Kuusisto J; Laakso M
PLoS One; 2014; 9(10):e109772. PubMed ID: 25310839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
